These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 26551285

  • 1. Epithelial-mesenchymal transition in prostatic disease.
    Broster SA, Kyprianou N.
    Future Oncol; 2015; 11(23):3197-206. PubMed ID: 26551285
    [Abstract] [Full Text] [Related]

  • 2. Estradiol promotes epithelial-to-mesenchymal transition in human benign prostatic epithelial cells.
    Shi X, Peng Y, Du X, Liu H, Klocker H, Lin Q, Shi J, Zhang J.
    Prostate; 2017 Oct; 77(14):1424-1437. PubMed ID: 28850686
    [Abstract] [Full Text] [Related]

  • 3. Evidence of TGF-β1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells.
    Hu S, Yu W, Lv TJ, Chang CS, Li X, Jin J.
    Mol Membr Biol; 2014 Oct; 31(2-3):103-10. PubMed ID: 24650126
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of β-catenin and mesenchymal markers in canine prostatic hyperplasia and carcinoma.
    Lean FZ, Kontos S, Palmieri C.
    J Comp Pathol; 2014 May; 150(4):373-81. PubMed ID: 24529514
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cellular senescence as a possible link between prostate diseases of the ageing male.
    Fiard G, Stavrinides V, Chambers ES, Heavey S, Freeman A, Ball R, Akbar AN, Emberton M.
    Nat Rev Urol; 2021 Oct; 18(10):597-610. PubMed ID: 34294916
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Profiling Prostate Cancer Therapeutic Resistance.
    Wade CA, Kyprianou N.
    Int J Mol Sci; 2018 Mar 19; 19(3):. PubMed ID: 29562686
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.
    Huang HF, Murphy TF, Shu P, Barton AB, Barton BE.
    Mol Cancer; 2005 Jan 12; 4(1):2. PubMed ID: 15647107
    [Abstract] [Full Text] [Related]

  • 16. Stromally expressed c-Jun regulates proliferation of prostate epithelial cells.
    Li W, Wu CL, Febbo PG, Olumi AF.
    Am J Pathol; 2007 Oct 12; 171(4):1189-98. PubMed ID: 17702894
    [Abstract] [Full Text] [Related]

  • 17. Predictive value of epithelial-mesenchymal-transition (EMT) signature and PARP-1 in prostate cancer radioresistance.
    Stark TW, Hensley PJ, Spear A, Pu H, Strup SS, Kyprianou N.
    Prostate; 2017 Dec 12; 77(16):1583-1591. PubMed ID: 29063620
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Stabilization of Snail through AKT/GSK-3β signaling pathway is required for TNF-α-induced epithelial-mesenchymal transition in prostate cancer PC3 cells.
    Wang H, Fang R, Wang XF, Zhang F, Chen DY, Zhou B, Wang HS, Cai SH, Du J.
    Eur J Pharmacol; 2013 Aug 15; 714(1-3):48-55. PubMed ID: 23769744
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.